Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29901 - 29925 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Decitabine	Approved Investigational	SLC6A8	6535	upregulated	decitabine results in increased expression of SLC6A8 mRNA	Xq28	A21917
Decitabine	Approved Investigational	SLC9A3	6550	upregulated	decitabine results in increased expression of SLC9A3 mRNA	5p15.33	A21915
Decitabine	Approved Investigational	SLCO2A1	6578	upregulated	decitabine results in increased expression of SLCO2A1 mRNA	3q22.1-q22.2	A21911
Decitabine	Approved Investigational	SLIT2	9353	upregulated	decitabine results in increased expression of SLIT2 mRNA	4p15.31	A22033
Decitabine	Approved Investigational	SMAD7	4092	upregulated	decitabine results in increased expression of SMAD7 mRNA	18q21.1	A20985
Decitabine	Approved Investigational	SNAI1	6615	upregulated	decitabine results in increased expression of SNAI1 mRNA	20q13.13	A21919
Decitabine	Approved Investigational	SNCA	6622	upregulated	decitabine results in increased expression of SNCA mRNA	4q22.1	A21912 A22034
Decitabine	Approved Investigational	SNRNP70	6625	upregulated	decitabine results in increased expression of SNRNP70 mRNA	19q13.33	A21917
Decitabine	Approved Investigational	SNX10	29887	upregulated	decitabine results in increased expression of SNX10 mRNA	7p15.2	A20985
Decitabine	Approved Investigational	SNX13	23161	downregulated	decitabine results in decreased expression of SNX13 mRNA	7p21.1	A20985
Decitabine	Approved Investigational	SOCS1	8651	upregulated	decitabine results in increased expression of SOCS1 mRNA	16p13.13	A22015
Decitabine	Approved Investigational	SOD2	6648	upregulated	decitabine results in increased expression of SOD2 mRNA	6q25.3	A22035
Decitabine	Approved Investigational	SOHLH2	54937	upregulated	decitabine results in increased expression of SOHLH2 mRNA	13q13.3	A21915
Decitabine	Approved Investigational	SOX15	6665	upregulated	decitabine results in increased expression of SOX15 mRNA	17p13.1	A21978
Decitabine	Approved Investigational	SOX17	64321	upregulated	decitabine results in increased expression of SOX17 mRNA	8q11.23	A22036
Decitabine	Approved Investigational	SOX30	11063	upregulated	decitabine results in increased expression of SOX30 mRNA	5q33.3	A22037
Decitabine	Approved Investigational	SOX9	6662	upregulated	decitabine results in increased expression of SOX9 mRNA	17q24.3	A21912
Decitabine	Approved Investigational	SP1	6667	upregulated	decitabine results in increased expression of SP1 mRNA	12q13.13	A21956
Decitabine	Approved Investigational	SP110	3431	upregulated	decitabine results in increased expression of SP110 mRNA	2q37.1	A21915
Decitabine	Approved Investigational	SPANXA1	30014	upregulated	decitabine results in increased expression of SPANXA1 mRNA	Xq27.2	A21915
Decitabine	Approved Investigational	SPANXD	64648	upregulated	decitabine results in increased expression of SPANXD mRNA	Xq27.2	A21915
Decitabine	Approved Investigational	SPARC	6678	upregulated	decitabine results in increased expression of SPARC mRNA	5q33.1	A22038 A22039
Decitabine	Approved Investigational	SPHK1	8877	upregulated	decitabine results in increased expression of SPHK1 mRNA	17q25.2	A20985
Decitabine	Approved Investigational	SPRR2A	6700	upregulated	decitabine results in increased expression of SPRR2A mRNA	1q21.3	A21919
Decitabine	Approved Investigational	SPZ1	84654	upregulated	decitabine results in increased expression of SPZ1 mRNA	5q14.1	A21919

Displaying entries 29901 - 29925 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability